Your browser doesn't support javascript.
loading
Factors associated with Acute Limb Ischemia in Cardiogenic Shock and downstream Clinical Outcomes: Insights from the Cardiogenic Shock Working Group.
Kochar, Ajar; Vallabhajosyula, Saraschandra; John, Kevin; Sinha, Shashank S; Esposito, Michele; Pahuja, Mohit; Hirst, Colin; Li, Song; Kong, Qiuyue; Li, Borui; Natov, Peter; Kanwar, Manreet; Hernandez-Montfort, Jaime; Garan, Reshad; Walec, Karol; Zazzali, Peter; Sangal, Paavni; Ton, Van-Khue; Zweck, Elric; Kataria, Rachna; Guglin, Maya; Vorovich, Esther; Nathan, Sandeep; Abraham, Jacob; Harwani, Neil M; Hickey, Gavin W; Wencker, Detlef; Schwartzman, Andrew D; Khalife, Wissam; Mahr, Claudius; Kim, Ju H; Bhimaraj, Arvind; Blumer, Vanessa; Faugno, Anthony; Burkhoff, Daniel; Kapur, Navin K.
Affiliation
  • Kochar A; Brigham and Women's Hospital, Boston, MA.
  • Vallabhajosyula S; Warren Alpert Medical School of Brown University and Lifespan Cardiovascular Institute, Providence, RI.
  • John K; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Sinha SS; Inova Heart and Vascular Institute, Inova Fairfax Campus, Falls Church, VA.
  • Esposito M; Medical University of South Carolina, Charleston, SC.
  • Pahuja M; University of Oklahoma Health Science Center, Oklahoma City, OK.
  • Hirst C; St. Peter's Health Partners Medical Associates, Albany, NY.
  • Li S; Institute for Advanced Cardiac Care, Medical City Healthcare, Dallas, TX.
  • Kong Q; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Li B; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Natov P; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Kanwar M; Cardiovascular Instittue at Allegheny Health Network, Pittsburgh, PA.
  • Hernandez-Montfort J; Baylor Scott & White Health, Advanced Heart Failure Program Clinic, Temple, TX.
  • Garan R; Beth Israel Deaconess Medical Center, Boston, MA.
  • Walec K; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Zazzali P; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Sangal P; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Ton VK; Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, MA.
  • Zweck E; Department of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
  • Kataria R; Warren Alpert Medical School of Brown University and Lifespan Cardiovascular Institute, Providence, RI.
  • Guglin M; Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN.
  • Vorovich E; Bluhm Cardiovascular Institute of Northwestern University, Chicago, IL.
  • Nathan S; University of Chicago, Chicago, IL.
  • Abraham J; Providence Heart Institute, Portland, OR.
  • Harwani NM; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Hickey GW; University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Wencker D; Baylor Scott & White Health, Advanced Heart Failure Program Clinic, Temple, TX.
  • Schwartzman AD; Maine Medical Center, Portland, ME.
  • Khalife W; University of Texas Medical Branch, Galveston, TX.
  • Mahr C; University of Washington Medical Center, Seattle, WA.
  • Kim JH; Houston Methodist Research Institute, Houston, TX.
  • Bhimaraj A; Houston Methodist Research Institute, Houston, TX.
  • Blumer V; Inova Heart and Vascular Institute, Inova Fairfax Campus, Falls Church, VA.
  • Faugno A; The Cardiovascular Center, Tufts Medical Center, Boston, MA.
  • Burkhoff D; Cardiovascular Research Foundation, New York, NY.
  • Kapur NK; The Cardiovascular Center, Tufts Medical Center, Boston, MA. Electronic address: Nkapur@tuftsmedicalcenter.org.
Article in En | MEDLINE | ID: mdl-38944132
ABSTRACT

BACKGROUND:

There are limited data depicting the prevalence and ramifications of acute limb ischemia (ALI) among cardiogenic shock (CS) patients.

METHODS:

We employed data from the Cardiogenic Shock Working Group (CSWG), a consortium including 33 sites. We constructed a multi-variable logistic regression to examine the association between clinical factors and ALI, we generated another logistic regression model to ascertain the association of ALI with mortality.

RESULTS:

There were 7,070 patients with CS and 399 (5.6%) developed ALI. Patients with ALI were more likely to be female (40.4% versus 29.4%) and have peripheral arterial disease (13.8% versus 8.3%). Stratified by maximum SCAI shock stage, the rates of ALI were stage B 0.0%, stage C 1.8%, stage D 4.1%, and stage E 10.3%. Factors associated with higher risk for ALI included peripheral vascular disease OR 2.24 (95% CI 1.53 - 3.23; p < 0.01) and ≥ 2 mechanical circulatory support (MCS) devices OR 1.66 (95% CI 1.24 - 2.21, p < 0.01). ALI was highest for VA-ECMO patients (11.6%) or VA-ECMO + IABP/Impella CP (16.6%) yet use of distal perfusion catheters was less than 50%. Mortality was 38.0% for CS patients without ALI but 57.4% for CS patients with ALI. ALI was significantly associated with mortality, adjusted OR 1.40 (95% CI 1.01 - 1.95, p < 0.01).

CONCLUSIONS:

The rate of ALI was 6% among CS patients. Factors most associated with ALI include peripheral vascular disease and multiple MCS devices. The downstream ramifications of ALI were dire with a considerably higher risk of mortality.
Key words

Full text: 1 Database: MEDLINE Language: En Journal: J Heart Lung Transplant Journal subject: CARDIOLOGIA / TRANSPLANTE Year: 2024 Type: Article Affiliation country: Morocco

Full text: 1 Database: MEDLINE Language: En Journal: J Heart Lung Transplant Journal subject: CARDIOLOGIA / TRANSPLANTE Year: 2024 Type: Article Affiliation country: Morocco